01 November 1999
Effect of glutamic acid, aspartic acid, glycine and gamma amino butyric acid on the growth of human leukemia and melanoma cells in vitro
Harrison Boldizasr, Bela Szende, Ferenc TimarMed Sci Monit 1999; 5(6): BR1059-1064 :: ID: 502974
Abstract
K 562 human leukemia cells and HT 168 melanoma cells were cultured for 72 hours in Minimal Essential Medium (MEM) with or without asparagine. (AspNH2) and supplemented with 2.6 mmol/l glycine (Gly), 1.9 mmol/l gamma amino butyric acid (GABA), 1.5 mmol/l aspartic acid (Asp) or 6.8 mmol/l glutamic acid (Glu). Gly significantly inhibited the proliferation of both types of tumor cells both in the presence and the absence of AspNH2. This inhibitory effect developed gradually, usually by the 48th hour of incubation. Some of the Gly-treated cells showed signs indicative of apoptosis. In AspNH2-free MEM both the control and the experimental cell groups (supplemented with Gly, GABA, Asp or Glu) showed much slower proliferation than in MEM containing AspNH2. The values obtained in GABA-supplemented MEM in 72 hour experiment did not differ significantly from the control. Glu and Asp induced a significant rise in the growth of leukemia cells by the 3rd day of incubation. The growth of melanoma cells in Glu- or Asp-containing MEM did not significantly
differ from the control but significantly exceeded the value obtained in MEM supplemented with Gly. It is supposed that Cl-transport into tumor cells decreases and Na+ transport increases as a result of changes in the extracellular/intracellular ratio of excitatory/inhibitory amino acids. This results in depolarization which maintains cell division. The results suggest that some non-essential, transmitter amino acids exert either inhibitory or stimulating effect on tumor cell proliferation. This finding may open up new possibilities in preventing tumor growth.
Keywords: leukaemia and melanoma cells, transmitter amino acids, tumor cell proliferation
Editorial
01 January 2026 : Editorial
Editorial: Increasing Awareness of Lung Cancer in Non-Smokers and Never-Smokers Challenges Current Approaches to Prevention and ScreeningDOI: 10.12659/MSM.952454
Med Sci Monit 2026; 32:e952454
In Press
Clinical Research
Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...Med Sci Monit In Press; DOI: 10.12659/MSM.951027
Clinical Research
Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...Med Sci Monit In Press; DOI: 10.12659/MSM.950516
Review article
Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.951283
Clinical Research
Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 AdultsMed Sci Monit In Press; DOI: 10.12659/MSM.950938
Most Viewed Current Articles
17 Jan 2024 : Review article 10,187,196
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
13 Nov 2021 : Clinical Research 3,708,487
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
14 Dec 2022 : Clinical Research 2,341,643
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 706,524
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387






